J Pharm Pharmacogn Res 2(Suppl. 1): S10, 2014
Special supplement with the abstract book of LATINFARMA 2013
CO 020: SUBJECT: NATIONAL BIOETHICS NETWORK AND RESEARCH IN PERU – RENABIP
Socualaya P, Minaya G, Ayala B and Fuentes D.
Introduction: 85% of Research Ethics Committees exist in Peru and they are concentrated in Lima. Most are private and only 2 of them account for over 50% of approvals of clinical trials nationwide. Thus, the National Institute of Health assumes the challenge of developing a national system of monitoring and control in research ethics, creating the National Network of Bioethics and Research in Peru (RENABIP).
Material and methods: Strategies for the implementation process of the RENABIP were raised to determine regional capabilities, develop and disseminate policies, national standards, guidelines and technical tools, advocate and implement the Regional Coordinating Centers of Institutional Ethics Committees Research, develop skills, alliances and cooperation agreements and determination of extension mechanisms, communication, expansion and sustainability.
Results: In July 2012, the process of implementing the RENABIP began in 12 regions of Peru, achieving to involve 277 authorities of Regional Coordinating Centers of Research Ethics Committees; technical meetings and/or workshops were also performed, and coordination with key stakeholders in each region for research management were established. In March of 2013, the virtual platform was implemented for education and training in national Bioethics. In April 2013, the Research Ethics Course started, in order to train and strengthen the members of the Research Ethics Committees of the regions, and in this way support the management of research regional health priorities.
Conclusions: Today we continue with the process of implementing the National Plan of strengthening and sustainability RENABIP; and it has been scheduled the monitoring and evaluation of the RENABIP.